Dong Shin, M.D.

Emory Clinic

Professor of Hematology and Oncology

Director, Clinical and Translational Cancer Prevention Program

Emory Healthcare Network Physician
Medical Oncology (Board certified since 1989)
Internal Medicine (Board certified since 1985)
Areas of Clinical Interest:
esophageal cancer
head & neck cancer
lung cancer
skin cancer
thyroid cancer
Office(s) Locations:
Winship Cancer Institute
1365 C Clifton Road, NE
Atlanta, GA30322
(404) 778-1900
Additional Spoken Language(s):
Year Started Practicing: 1988
Year Started Practicing at Emory: 2003
Organizational Memberships:
American Association of Cancer Research
American College of Physicians
American Head and Neck Society
American Society of Clinical Oncology
Major or Recent Publications:

Combined interferon-á, 13-cis-retinoic acid and á-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel Bioadjuvant Phase II trial. Journal of Clinical Oncology,19:3010-1017, 2001.

P53 protein accumulation and genomic instability in head and neck tumorigenesis.. Cancer Epidermiol Biomarkers and Prevention,10:603-609, 2001.

Phase II Study of Induction Chemotherapy with Paclitaxel, Ifosfamid, and Carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer,95:340-353, 2002.

Phase II and biologic study of interferon-á, 13-cis-retinoic acid, and cisplatin in advanced squamous skin cancer.. Journal of Clinical Oncology,20:364-370, 2002.

Targeting epidermal growth factor receptor: A novel therapeutics in the management of cancer. Exp Reve Anticancer Therapy,3:367-380, 2003.

Medical School
Yonsei University, Seoul, Korea

Yonsei University, Seoul, Korea

Cook County Hospital,Chicago,IL

University of Texas, Austin, TX